Drug intelligence / Profile preview

Sip2Sleep

Development stage
Preclinical
Lead developer
Lakshmi Nutraceuticals
Administration
Oral
01

Overview

Sip2Sleep is a natural, plant-based sleep aid formulation consisting of Montmorency tart cherry extract and Venetron, a purified extract of *Apocynum venetum* (Rafuma). Developed by Lakshmi Nutraceuticals and created by Dr. Ruchir P. Patel, the product is designed to address sleep disorders including insomnia and anxiety. The *Apocynum venetum* component is clinically shown to increase GABA levels, promoting relaxation and improving sleep quality, while the tart cherry extract provides natural sources of melatonin and anthocyanins to support the sleep-wake cycle. Clinical studies conducted by People Science have demonstrated that the mixture statistically improves subjective sleep quality, daytime alertness, and insomnia symptoms without significantly impacting sleep duration or latency.

Brand names
Sip2SleepSip-2SleepSip 2Sleep
Other names
montmorency tart cherry extract + apocynum venetum extractRafuma Leaf extract
02

Targets

GABA-B (Gamma-aminobutyric acid receptor type B)MTNR1A (MT1)

Beyond the preview

Go deeper on Sip2Sleep.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sip2Sleep.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call